Whalen Kathleen M
Former Officer at HCA
- Sold, on record
- $8.2M
- Dollars the filings state
- Form 4 sales
- 15
- Latest Nov 14, 2024
- Form 144 notices
- 7
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- HCAHCA Healthcare, Inc.Former Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice HCANoticeMay 16, 2024 2024
Filed to sell 3,204 shares ($1M)
Whalen Kathleen M, Officer
No 10b5-1 plan1.1x usual sizeFiling
- 2 Form 4 sale HCAUnusualMay 16, 2024 same day
Sold 3,204 shares at $326.30 ($1M)
Whalen Kathleen M, SVP & Chief Ethics Officer
No 10b5-1 planSold 25.3% of holdings ($4.1M position)9,454 shares left1.1x usual sizeFollows a Form 144Filing
- 3 Form 144 notice HCANoticeJul 29, 2024 +74 days
Filed to sell 1,864 shares ($671k)
Whalen Kathleen M, Officer
No 10b5-1 plan0.6x usual sizeFiling
- 4 Form 144 notice HCANoticeJul 31, 2024 +2 days
Filed to sell 2,987 shares ($1.1M)
Whalen Kathleen M, Officer
No 10b5-1 plan1x usual sizeFiling
- 5 Form 4 sale HCAUnusualJul 31, 2024 same day
Sold 4,851 shares at $362.13 ($1.8M)
Whalen Kathleen M, SVP & Chief Ethics Officer
No 10b5-1 planSold 33.9% of holdings ($5.2M position)9,454 shares left1.6x usual sizeFollows a Form 144Filing
- 6 Form 144 notice HCANoticeNov 14, 2024 +106 days
Filed to sell 1,474 shares ($528k)
Whalen Kathleen M, Officer
No 10b5-1 plan0.5x usual sizeFiling
- 7 Form 4 sale HCANo planNov 14, 2024 same day
Sold 1,474 shares at $357.99 ($528k)
Whalen Kathleen M, SVP & Chief Ethics Officer
No 10b5-1 planSold 13.5% of holdings ($3.9M position)9,454 shares left0.5x usual sizeFollows a Form 144Filing
- 8 Form 144 notice HCANoticeJan 31, 2025 +78 days
Filed to sell 3,228 shares ($1.1M)
Whalen Kathleen M, Former Officer
No 10b5-1 plan1.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (22)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | Jan 31, 2025 | HCA | Former Officer | Form 144 notice | 3,228 | $1.1M | Notice | SEC | |
| Nov 14, 2024 | Nov 18, 2024 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 1,474 | $528k | 13.5% | No plan | SEC |
| Nov 14, 2024 | Nov 14, 2024 | HCA | Officer | Form 144 notice | 1,474 | $528k | Notice | SEC | |
| Jul 31, 2024 | Jul 31, 2024 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 4,851 | $1.8M | 33.9% | Unusual | SEC |
| Jul 31, 2024 | Jul 31, 2024 | HCA | Officer | Form 144 notice | 2,987 | $1.1M | Notice | SEC | |
| Jul 29, 2024 | Jul 29, 2024 | HCA | Officer | Form 144 notice | 1,864 | $671k | Notice | SEC | |
| May 16, 2024 | May 20, 2024 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 3,204 | $1M | 25.3% | Unusual | SEC |
| May 16, 2024 | May 16, 2024 | HCA | Officer | Form 144 notice | 3,204 | $1M | Notice | SEC | |
| Feb 9, 2024 | Feb 13, 2024 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 4,262 | $1.3M | 29.4% | Unusual | SEC |
| Feb 9, 2024 | Feb 9, 2024 | HCA | Officer | Form 144 notice | 4,262 | $1.3M | Notice | SEC | |
| Aug 3, 2023 | Aug 7, 2023 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 2,916 | $787k | 22.1% | No plan | SEC |
| Aug 3, 2023 | Aug 3, 2023 | HCA | Officer | Form 144 notice | 2,916 | $787k | Notice | SEC | |
| Feb 17, 2023 | Feb 22, 2023 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 1,734 | $457k | 14.8% | Plan not stated | SEC |
| May 3, 2022 | May 5, 2022 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 500 | $108k | 4.2% | Plan not stated | SEC |
| Nov 4, 2021 | Nov 4, 2021 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 3,815 | $956k | 30.1% | Unusual | SEC |
| Jul 22, 2021 | Jul 26, 2021 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 886 | $219k | 9.1% | Plan not stated | SEC |
| Feb 4, 2021 | Feb 5, 2021 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 280 | $50k | 7.1% | Plan not stated | SEC |
| Oct 29, 2020 | Nov 2, 2020 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 1,268 | $158k | 24.2% | Plan not stated | SEC |
| Feb 7, 2020 | Feb 11, 2020 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 1,956 | $286k | 33.0% | Unusual | SEC |
| Nov 4, 2019 | Nov 6, 2019 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 2,540 | $343k | 30.0% | Unusual | SEC |
| Aug 13, 2019 | Aug 15, 2019 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 977 | $125k | 10.4% | Plan not stated | SEC |
| Feb 6, 2019 | Feb 8, 2019 | HCA | SVP & Chief Ethics Officer | Form 4 sale | 200 | $28k | 3.1% | Plan not stated | SEC |